Omeros | OMER - Stock


Omeros reported $712K in Stock for its fiscal quarter ending in September of 2021.





Stock Change Date
Adma Biologics USD 222.1M 15.63M Mar/2026
Alnylam Pharmaceuticals USD 200.15M 117.43M Mar/2026
BioMarin Pharmaceutical USD 1.27B 25.66M Mar/2026
Gilead Sciences USD 1.91B 140M Mar/2026
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Insmed USD 132.91M 841K Mar/2026
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
MacroGenics USD 9.5M 1.59M Mar/2026
Omeros USD 712K 266K Sep/2021
Pacira USD 150.37M 2.49M Mar/2026
Pfizer USD 10.67B 13M Mar/2026
Rockwell Medical USD 4.16M 885K Jun/2025
Sarepta Therapeutics USD 1B 86.37M Mar/2026
United Therapeutics USD 178.3M 4.8M Mar/2026
Vertex Pharmaceuticals USD 1.77B 79.9M Mar/2026